Paul D. Goldenheim

Former Board Member at Momenta Pharmaceuticals, Inc.

Are you Paul D. Goldenheim? Claim your profile
 
  • IDENTIFY executive and board member connections in Paul D. Goldenheim's network.
  • FOLLOW changes in Paul D. Goldenheim's employment.
  • CONNECT with Paul D. Goldenheim through your network of contacts.

Paul D. Goldenheim's Executive Work History


Past
To view Paul D. Goldenheim's complete executive work history,
Education
Age
-
 

Paul D. Goldenheim's Biography


Dr. Goldenheim joined the NeuroPhage Board of Directors in March 2010. Dr. Goldenheim is trained as a pulmonary physician and is currently working as a director and consultant in the field of biotechnology, serving on the boards of directors of several companies including Alinea, Promedior, and Hydra Biosciences. He has a long history in pharmaceutical research, development, and management, most recently as President of TransForm Pharmaceuticals (acquired by Johnson & Johnson) and Vice-Chairman of the Board of Directors of Hypnion (acquired by Eli Lilly). Paul also serves on the board of directors of The Big Apple Circus. Dr. Goldenheim has a ...

(Read More)

Source: NEUROPHAGE PHARMACEUTICALS INC on 04/28/2006

 
 

By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Paul D. Goldenheim. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Paul D. Goldenheim's network.
  • FOLLOW changes in Paul D. Goldenheim's employment.
  • CONNECT with Paul D. Goldenheim through your network of contacts.
 

Access over 200,000 executive and board member profiles.

/bio

Example: Paul D. Goldenheim

Paul D. Goldenheim's Connections (25)


Former Chairman of the Board, Catalyst Biosciences, Inc.
Former Senior Vice President, Pharmaceutical Sciences, Momenta Pharmaceuticals, Inc.
Former Board Member and Chief Executive Officer, PARASOL THERAPEUTICS INC
President, Chief Executive Officer and Director, Momenta Pharmaceuticals, Inc.
Executive in Transition and Former Chief Operating Officer and Chief Scientific Officer, Momenta Pharmaceuticals, Inc.

Popular Profiles